azomycin has been researched along with tretazicar in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walton, MI; Wolf, CR; Workman, P | 1 |
| Adams, GE | 1 |
| Melo, T; Misra, V; Rauth, AM | 1 |
3 other study(ies) available for azomycin and tretazicar
| Article | Year |
|---|---|
Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Biotransformation; Carbon Monoxide; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytosol; Male; Mice; Mice, Inbred C3H; Microsomes, Liver; Nitroimidazoles; Oxidation-Reduction; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1989 |
Radiosensitizers: a conference preview.
Topics: Animals; Aziridines; Buthionine Sulfoximine; Carmustine; Combined Modality Therapy; Drug Synergism; Etanidazole; Humans; Ketones; Lomustine; Maleates; Methionine Sulfoximine; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Bioreductive therapies: an overview of drugs and their mechanisms of action.
Topics: Animals; Antineoplastic Agents; Aziridines; Cell Hypoxia; DNA, Neoplasm; Forecasting; Humans; Indolequinones; Indoles; Misonidazole; Mitomycin; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Prodrugs; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1998 |